Back to search

A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

Data up to Jan 2025

Published2009
Citations29
References18

Total Citations Per Year

Abstract

References (18)

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

2005 • 5,383 citations

Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

2000 • 1,359 citations

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

2001 • 1,126 citations

Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation

2002 • 713 citations

The IL-2 Receptor Complex: Its Structure, Function, and Target Genes

1993 • 601 citations

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

1995 • 257 citations

Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic Potential

2005 • 239 citations

Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor.

1987 • 234 citations

DAB389IL-2 (Denileukin Diftitox, ONTAK): A New Fusion Protein Technology

2000 • 54 citations

Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells

1991 • 48 citations

Differential expression of interleukin‐2 receptors (α and β chain) in mature lymphoid neoplasms

1994 • 43 citations

Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma

1992 • 41 citations

Elevated Concentration of Soluble Interleukin-2 Receptors in Serum of Smokers and Patients with Lung Cancer: Correlation with Clinical Activity

1990 • 33 citations

Soluble interleukin-2 receptors and other markers in primary lung cancer

1991 • 30 citations

The clinicopathological significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small-cell lung cancer patients

2000 • 24 citations

Interleukin-2 receptors in pulmonary adenocarcinoma tissue

1996 • 21 citations

The clinical significance of serum soluble interleukin-2 receptors in lung cancer

1996 • 16 citations

The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.

2001 • 13 citations

Cited By (0)

Loading...
A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced… (2009) – American Journal of Clinical Oncology | Metascience Observatory Explorer